Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-31

Clinical Trial Update: Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial comparing Lipiodol/ethiodized oil with drug-eluting beads for hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Drug-eluting beads (drug-eluting beads (DEB))
  • Lipiodol (Ethiodized oil)

Snippet

Sponsor: University of Minnesota | Conditions: Hepatocellular Carcinoma | NA | Status: WITHDRAWN